e-learning
resources
Milan 2017
Sunday, 10.09.2017
COPD management: new findings from large studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality?
R. Sicilia Torres (LAS PALMAS DE GRAN CANARIA, Spain)
Source:
International Congress 2017 – COPD management: new findings from large studies
Session:
COPD management: new findings from large studies
Session type:
Oral Presentation
Number:
1498
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Sicilia Torres (LAS PALMAS DE GRAN CANARIA, Spain). Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality?. 1498
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
GOLD 2017 versus GOLD 2011 - comparison of the risk of exacerbations and mortality in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
GOLD 2011 versus GOLD 2017 – What does change?
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Mortality and exacerbation prediction by GOLD groups ABCD 2011 vs. 2017: analysis of the COPDGene cohort
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients.
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015
The 2006 and 2011 GOLD classifications and five-years mortality in COPD
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Validation of the GOLD 2017 classification in predicting exacerbations and mortality in COPD patients
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Incidence and outcomes of hospitalized for COPD exacerbations with and without pneumonia, 2006-2012: A nationwide cohort study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Results of a pulmonary rehabilitation program (PRP) in COPD patients: Differences in outcomes according to currently 2011 GOLD groups
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
LATE-BREAKING ABSTRACT: Risk factors for osteoporosis in patients with COPD: 2008-2010 Korean NHANES
Source: International Congress 2014 – Comorbidities
Year: 2014
Asthma hospitalization rates and asthma mortality in Chilean Children: 2008-2014
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
The 2013 updated GOLD strategy: A comparison of the various scenarios
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept